ReP USP - Resultado da busca

Artigo de periodico
Photodynamic treatment of malignant melanoma with structured light: in silico Monte Carlo modeling (2024)
Doronin, Alexander ; Yakovlev, Vladislav ; Bagnato, Vanderlei Salvador
Source: Biomedical Optics Express. Unidade: IFSC
Subjects: TERAPIA FOTODINÂMICA, NEOPLASIAS, MELANOMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DORONIN, Alexander e YAKOVLEV, Vladislav e BAGNATO, Vanderlei Salvador. Photodynamic treatment of malignant melanoma with structured light: in silico Monte Carlo modeling. Biomedical Optics Express, v. 15, n. 3, p. 1682-1693, 2024Tradução . . Disponível em: https://doi.org/10.1364/BOE.515962. Acesso em: 03 nov. 2024.
APA
Doronin, A., Yakovlev, V., & Bagnato, V. S. (2024). Photodynamic treatment of malignant melanoma with structured light: in silico Monte Carlo modeling. Biomedical Optics Express, 15( 3), 1682-1693. doi:10.1364/BOE.515962
NLM
Doronin A, Yakovlev V, Bagnato VS. Photodynamic treatment of malignant melanoma with structured light: in silico Monte Carlo modeling [Internet]. Biomedical Optics Express. 2024 ; 15( 3): 1682-1693.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1364/BOE.515962
Vancouver
Doronin A, Yakovlev V, Bagnato VS. Photodynamic treatment of malignant melanoma with structured light: in silico Monte Carlo modeling [Internet]. Biomedical Optics Express. 2024 ; 15( 3): 1682-1693.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1364/BOE.515962
Artigo de periodico
Preclinical development of seriniquinones as selective dermcidin modulators for the treatment of melanoma (2022)
Hirata, Amanda Soares ; Clair, James J. La ; Jimenez, Paula C. ; Costa-Lotufo, Letícia Veras ; Fenical, William
Source: Marine Drugs. Unidade: ICB
Subjects: FARMACOLOGIA, CÉLULAS CULTIVADAS DE TUMOR, APOPTOSE, PRODUTOS NATURAIS, MELANOMA, NEOPLASIAS CUTÂNEAS, MOLÉCULA, INFECÇÕES BACTERIANAS GRAM-POSITIVAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HIRATA, Amanda Soares et al. Preclinical development of seriniquinones as selective dermcidin modulators for the treatment of melanoma. Marine Drugs, v. 20, n. 5, p. 1-13, 2022Tradução . . Disponível em: https://doi.org/10.3390/md20050301. Acesso em: 03 nov. 2024.
APA
Hirata, A. S., Clair, J. J. L., Jimenez, P. C., Costa-Lotufo, L. V., & Fenical, W. (2022). Preclinical development of seriniquinones as selective dermcidin modulators for the treatment of melanoma. Marine Drugs, 20( 5), 1-13. doi:10.3390/md20050301
NLM
Hirata AS, Clair JJL, Jimenez PC, Costa-Lotufo LV, Fenical W. Preclinical development of seriniquinones as selective dermcidin modulators for the treatment of melanoma [Internet]. Marine Drugs. 2022 ; 20( 5): 1-13.[citado 2024 nov. 03 ] Available from: https://doi.org/10.3390/md20050301
Vancouver
Hirata AS, Clair JJL, Jimenez PC, Costa-Lotufo LV, Fenical W. Preclinical development of seriniquinones as selective dermcidin modulators for the treatment of melanoma [Internet]. Marine Drugs. 2022 ; 20( 5): 1-13.[citado 2024 nov. 03 ] Available from: https://doi.org/10.3390/md20050301
Artigo de periodico
Ablation of sensory nerves favours melanoma progression (2020)
Prazeres, Pedro H. D. M.; Leonel, Caroline; Silva, Walison N.; Rocha, Beatriz G. S; Santos, Gabryella S. P.; Costa, Alinne C.; Picoli, Caroline C.; Sena, Isadora F. G.; Gonçalves, William Antônio; Vieira, Mariana S.; Costa, Pedro A. C.; Campos, Leda M. C. Coimbra; Lopes, Míriam Tereza Paz; Costa, Marcos R.; Resende, Rodrigo R.; Cunha, Thiago Mattar; Mintz, Akiva; Birbrair, Alexander
Source: Journal of Cellular and Molecular Medicine. Unidade: FMRP
Subjects: INTERAÇÃO CELULAR, LINHAGEM CELULAR, MELANOMA, ESTUDOS RETROSPECTIVOS, NEOPLASIAS, PELE, PATOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PRAZERES, Pedro H. D. M. et al. Ablation of sensory nerves favours melanoma progression. Journal of Cellular and Molecular Medicine, v. 24, n. 17, p. 9574-9589, 2020Tradução . . Disponível em: https://doi.org/10.1111/jcmm.15381. Acesso em: 03 nov. 2024.
APA
Prazeres, P. H. D. M., Leonel, C., Silva, W. N., Rocha, B. G. S., Santos, G. S. P., Costa, A. C., et al. (2020). Ablation of sensory nerves favours melanoma progression. Journal of Cellular and Molecular Medicine, 24( 17), 9574-9589. doi:10.1111/jcmm.15381
NLM
Prazeres PHDM, Leonel C, Silva WN, Rocha BGS, Santos GSP, Costa AC, Picoli CC, Sena IFG, Gonçalves WA, Vieira MS, Costa PAC, Campos LMCC, Lopes MTP, Costa MR, Resende RR, Cunha TM, Mintz A, Birbrair A. Ablation of sensory nerves favours melanoma progression [Internet]. Journal of Cellular and Molecular Medicine. 2020 ; 24( 17): 9574-9589.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1111/jcmm.15381
Vancouver
Prazeres PHDM, Leonel C, Silva WN, Rocha BGS, Santos GSP, Costa AC, Picoli CC, Sena IFG, Gonçalves WA, Vieira MS, Costa PAC, Campos LMCC, Lopes MTP, Costa MR, Resende RR, Cunha TM, Mintz A, Birbrair A. Ablation of sensory nerves favours melanoma progression [Internet]. Journal of Cellular and Molecular Medicine. 2020 ; 24( 17): 9574-9589.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1111/jcmm.15381
Artigo de periodico
Epigenetic silencing of CDR1as drives IGF2BP3-mediated melanoma invasion and metastasis (2020)
Hanniford, Douglas; Ulloa-Morales, Alejandro; Karz, Alcida; Coelho, Maria Gabriela Berzoti ; Moubarak, Rana S.; Sánchez-Sendra, Beatriz; Kloetgen, Andreas; Davalos, Veronica; Imig, Jochen; Wu, Pamela; Vasudevaraja, Varshini; Argibay, Diana; Lilja, Karin; Tabaglio, Tommaso; Monteagudo, Carlos; Guccione, Ernesto; Tsirigos, Aristotelis; Osman, Iman; Aifantis, Iannis; Hernando, Eva
Source: Cancer Cell. Unidade: FCFRP
Subjects: MELANOMA, METÁSTASE NEOPLÁSICA, NEOPLASIAS, RNA, CARCINOGÊNESE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HANNIFORD, Douglas et al. Epigenetic silencing of CDR1as drives IGF2BP3-mediated melanoma invasion and metastasis. Cancer Cell, v. 37, n. 1, p. 55-70.e1-e15, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.ccell.2019.12.007. Acesso em: 03 nov. 2024.
APA
Hanniford, D., Ulloa-Morales, A., Karz, A., Coelho, M. G. B., Moubarak, R. S., Sánchez-Sendra, B., et al. (2020). Epigenetic silencing of CDR1as drives IGF2BP3-mediated melanoma invasion and metastasis. Cancer Cell, 37( 1), 55-70.e1-e15. doi:10.1016/j.ccell.2019.12.007
NLM
Hanniford D, Ulloa-Morales A, Karz A, Coelho MGB, Moubarak RS, Sánchez-Sendra B, Kloetgen A, Davalos V, Imig J, Wu P, Vasudevaraja V, Argibay D, Lilja K, Tabaglio T, Monteagudo C, Guccione E, Tsirigos A, Osman I, Aifantis I, Hernando E. Epigenetic silencing of CDR1as drives IGF2BP3-mediated melanoma invasion and metastasis [Internet]. Cancer Cell. 2020 ; 37( 1): 55-70.e1-e15.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1016/j.ccell.2019.12.007
Vancouver
Hanniford D, Ulloa-Morales A, Karz A, Coelho MGB, Moubarak RS, Sánchez-Sendra B, Kloetgen A, Davalos V, Imig J, Wu P, Vasudevaraja V, Argibay D, Lilja K, Tabaglio T, Monteagudo C, Guccione E, Tsirigos A, Osman I, Aifantis I, Hernando E. Epigenetic silencing of CDR1as drives IGF2BP3-mediated melanoma invasion and metastasis [Internet]. Cancer Cell. 2020 ; 37( 1): 55-70.e1-e15.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1016/j.ccell.2019.12.007

USP Schools

ReP

Filtros

Authors

Subjects

Funding Agencies

Indexado em

Non normalized affiliation